Market Tracker

09/18 7:27am ET

Cytokinetics Inc (NASDAQ:CYTK)

3.87
Data as of Sep 17
 +0.12 / +3.20%
Today’s Change
3.58
Today|||52-Week Range
13.26
-40.46%
Year-to-Date

Today’s Trading

Previous close3.75
Today’s open3.79
Day’s range-- - --
Volume262,533
Average volume (3 months)519,421
Market cap$137.3M
Dividend yield--
Data as of 09/17/2014

Growth & Valuation

Earnings growth (last year)+45.61%
Earnings growth (this year)+18.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+305.45%
P/E ratioNM
Price/Sales5.78
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+0.19+2.07%
ISRIsoRay Inc-0.03-1.29%
LFVNLifeVantage Corp0.000.00%
TRGTTargacept Inc+0.06+2.40%
Data as of 09/17/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$30.6M
Annual profit (last year)-$33.7M
Net profit margin-110.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts